EA201990307A1 - COMPOSITIONS CONTAINING SILICON DIOXIDE NANOPARTICLES AND THEIR APPLICATION IN METHODS OF ACTIVATION OF T-LYMPHOCYTES IN THERAPY - Google Patents
COMPOSITIONS CONTAINING SILICON DIOXIDE NANOPARTICLES AND THEIR APPLICATION IN METHODS OF ACTIVATION OF T-LYMPHOCYTES IN THERAPYInfo
- Publication number
- EA201990307A1 EA201990307A1 EA201990307A EA201990307A EA201990307A1 EA 201990307 A1 EA201990307 A1 EA 201990307A1 EA 201990307 A EA201990307 A EA 201990307A EA 201990307 A EA201990307 A EA 201990307A EA 201990307 A1 EA201990307 A1 EA 201990307A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- lymphocytes
- activation
- silicon dioxide
- compositions containing
- therapy
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Описаны композиции, содержащие частицы диоксида кремния, имеющие средний размер, определенный стандартными способами определения размера, от 0,5 до 20 нм, для применения при активации лимфоцитов в культуре или цельной крови.Describes compositions containing particles of silicon dioxide having an average size determined by standard methods of determining size, from 0.5 to 20 nm, for use in the activation of lymphocytes in culture or whole blood.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1701827.6A GB201701827D0 (en) | 2017-02-03 | 2017-02-03 | Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy |
PCT/EP2017/070183 WO2018029247A1 (en) | 2016-08-10 | 2017-08-09 | Compositions comprising nanosilica particles and their use in methods of activating t lymphocytes for therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201990307A1 true EA201990307A1 (en) | 2019-08-30 |
Family
ID=58462464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201990307A EA201990307A1 (en) | 2017-02-03 | 2017-08-09 | COMPOSITIONS CONTAINING SILICON DIOXIDE NANOPARTICLES AND THEIR APPLICATION IN METHODS OF ACTIVATION OF T-LYMPHOCYTES IN THERAPY |
Country Status (2)
Country | Link |
---|---|
EA (1) | EA201990307A1 (en) |
GB (1) | GB201701827D0 (en) |
-
2017
- 2017-02-03 GB GBGB1701827.6A patent/GB201701827D0/en not_active Ceased
- 2017-08-09 EA EA201990307A patent/EA201990307A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
GB201701827D0 (en) | 2017-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019500862A1 (en) | Novel cd47 monoclonal antibodies and uses thereof | |
MX2019007587A (en) | Ophthalmic composition for treatment of dry eye disease. | |
PH12016500575A1 (en) | Inhibitors of bruton`s tyrosine kinase | |
MX2019007480A (en) | Monoclonal anti-alpha-synuclein antibodies for preventing tau aggregation. | |
WO2014176128A3 (en) | Compositions and methods for the therapy and diagnosis of influenza | |
EA201992546A1 (en) | MEANS ON THE BASIS OF ANTIBODIES TO CD33 | |
CY1121849T1 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | |
MA39248B1 (en) | Anti-jagged1 antibodies and methods of use thereof | |
MX2017002085A (en) | Protein/oligonucleotide core-shell nanoparticle therapeutics. | |
BR112017000464A2 (en) | gamma delta t cells and their use | |
EA201592203A1 (en) | METHODS OF TREATMENT OF Taupathy | |
PH12018500887A1 (en) | Anti-htra1 antibodies and methods of use thereof | |
EA202191513A1 (en) | REDUCING THE VISCOSITY OF PHARMACEUTICAL COMPOSITIONS | |
EA201992175A1 (en) | COMPOSITIONS AND METHODS INCLUDING PROBIOTIC MOLECULES | |
WO2014145485A3 (en) | Map kinase modulators and uses thereof | |
EA201891609A1 (en) | DERIVATIVES 3 - ((HETERO-) ARYL) ALKYL-8-AMINO-2-OXO-1,3-DIAZASPIRO [4.5] DECANE | |
EA201891611A1 (en) | DERIVATIVES 3 - ((HETERO-) Aryl) -8-AMINO-2-OXO-1,3-DIAZASPIRO [4,5] DEAN | |
EA201891610A1 (en) | DERIVATIVES 3- (CARBOXYETHYL) -8-AMINO-2-OXO-1,3-DIAZASPIRO [4.5] DEAN | |
MA39228A1 (en) | Compositions for use in treating allergic conditions | |
WO2018033941A3 (en) | Pharmaceutical compositions of ibrutinib | |
MX2021001361A (en) | Liquid human fibrinogen composition. | |
EA201990307A1 (en) | COMPOSITIONS CONTAINING SILICON DIOXIDE NANOPARTICLES AND THEIR APPLICATION IN METHODS OF ACTIVATION OF T-LYMPHOCYTES IN THERAPY | |
MX2017006491A (en) | Compositions and methods for modulating at2r activity. | |
MA40817A (en) | LONG-ACTION COMBINATION COMPOSITIONS AND METHODS FOR CONTROLLING HEPATITIS C | |
PH12018502139A1 (en) | Phosphaplatin liquid formulations |